Market Data graphic

Life Sciences

You are here

The Life Sciences sector includes companies involved in biopharmaceuticals, medical manufacturing and distribution, and bio products.

Life sciences companies listed on CSE

Heritage is a leading cannabis company offering innovative products to both the medical and recreational legal cannabis markets in Canada and the U.S., operating two licensed manufacturing facilities in Canada. The company has an extensive portfolio of high-quality cannabis products under the brands Purefarma, Pura Vida, RAD, Adults Only, Juicy Hoots, Premium 5, Thrifty, feelgood., the CB4 suite of medical products in Canada and ArthroCBD in the U.S.

HYTN Innovations Inc. formulates, manufactures, markets, and sells premium products that contain psychoactive and psychotropic compounds. The company’s mission is to become the top provider of these products in all federally regulated markets. To achieve this, the company focuses on identifying market opportunities in order to quickly bring its innovative products to market through its elevated development platform.

Pideka Group Inc., (formerly known as Ikänik Farms) is multi-national operator with a medical grade indoor cultivation facility and laboratory (Pideka SAS) in Bogata Colombia which holds EU GMP, (GMP-PHARMA) and Good Agricultural and Collection Practice (GACP) certifications. 

Investor Note: In addition to the 168,101,981 Subordinate Voting Shares that are listed and trading, there are 14,935,500 shares reserved specifically for issuance pursuant to the conversion rights attached to the Series A Multiple Voting Shares that are issued and outstanding but not listed.  The total number of equity shares assuming all are converted into the listed class would be 183,037,481.

IMCC is an international medical cannabis company, and a well-known Israeli brand of medical cannabis products. In Europe, IMCC is establishing a fully operational, vertically integrated medical cannabis business spearheaded by its distribution arm in Germany and augmented by strategic agreements with certified EU-GMP Standard suppliers, making it one of the only medical cannabis companies with fully integrated operations in Europe. IMCC intends to leverage IMCC's brand to establish a foothold in emerging medical cannabis markets including Germany, Portugal and Greece.

The Corporation's business can be described as three distinct operating segments relating to the incorporation in products of CBD in their formulation: (i) research, development, marketing, distribution and sales of InnoCan-branded OTC pharmaceutical products; (ii) research and development of non-pharmaceutical products for third parties in exchange for fees and/or royalties; and (iii) research and development of hydrogels containing liposomes intended for licensing or sale to third party pharmaceutical corporations for manufacturing, distribution and sales.

IONIC BRANDS Corp. is dedicated to building a regionally based multi-state consumer-focused cannabis concentrate brand portfolio with strong roots in the premium and luxury segments of vape concentrates and edibles. The cornerstone brand of the portfolio, IONIC, is a top vaporizer brand in Washington State along with its economy brand Dabulous and has aggressively expanded throughout the Pacific Northwest of the United States. The brand is currently operating in Washington and Oregon. IONIC BRANDS' strategy is to be the leader of the highest-value segments of the cannabis market.

Each whole Warrant shall entitle each Warrantholder thereof, upon exercise at any time after the issue thereof and prior to the Expiry Time, to acquire one (1) Warrant Share upon payment of the Exercise Price of $0.30.

See the Warrant Indenture for full details.

Irwin Naturals is a nutraceutical company that distributes dietary supplements to more than 100,000 retailers, including mass-market retailers.

Investor Note: In addition to the 3,369,368 Subordinate Voting Shares that are listed and trading, there are (i) 340,300 subordinate voting shares reserved for issuance pursuant to the conversion rights attached to the Proportionate Voting Shares of Irwin Naturals Inc. (ii) 18,240 subordinate voting shares reserved for issuance pursuant to the conversion rights attached to the Multiple Voting Shares of Irwin Naturals Inc.; (iii) 320,000,000 subordinate voting shares reserved for issuance pursuant to the exchange rights attached to the Class B Non-Voting Shares of Irwin Naturals, an indirect, wholly-owned subsidiary of Irwin Naturals Inc.; and (iv) 20,000 subordinate voting share purchase warrants.  The total number of equity shares assuming all are converted or exchanged, as applicable, into the listed class would be 323,747,908.

Isracann Biosciences Inc. is an Israeli-based company focused on becoming a premier cannabis producer offering low-cost production targeting undersupplied major European marketplaces. Based in Israel's agricultural sector, Isracann will leverage its development within the most experienced country in the world with respect to cannabis research.

Contact The Team

How can we help you?

Contact the CSE team to find out more.